74 results
Page 2 of 4
8-K
EX-99.1
6nw4i9po
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.2
j34dc
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.1
d0uodycp 3svvsa10fv
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-99.2
x0mbh43f3tusop7p2fd
26 Jun 20
Other Events
5:08pm
8-K
EX-99.1
p5130grqvvqk
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
uro4me hi3
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-14.1
y43aec hflj73v36l
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-99.1
we9u4l3ps63guuq
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
xijdi8mpd3z
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
wbhnw5gahg7op0d
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
pylzo9zr i00w
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
84ss49c
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-2.1
j1umt7
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-2.1
0vzxc 6b4pdc
18 Dec 19
Additional proxy soliciting materials
8:11am